HCW Biologics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HCWB | GRI | AIM | IMMP | SCNI | QTTB | |
|---|---|---|---|---|---|---|
| Market cap | 2.42M | 3.13M | 6.42M | 21.74M | 1.18M | 267.03M |
| P/E (TTM) | — | — | — | — | 0.0 | 2.5 |
| Forward P/E | -2.0 | -0.7 | -0.4 | -0.9 | — | -8.8 |
| Price/book | 0.2 | 0.3 | 0.6 | 0.5 | 0.0 | 2.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −94.21% | −96.73% | −90.12% | −91.38% | −95.93% | +266.53% |
| Today | −6.09% | −7.14% | +0.19% | −1.50% | −4.92% | +2.40% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All HCWB news ›HCW Biologics Inc. (NASDAQ:HCWB) Sees Significant Decrease in Short Interest
Posted by Danessa Lincoln on Nov 2nd, 2026 Get Our Latest Stock Report on HCW Biologics HCW Biologics Inc (NASDAQ: HCWB) is a clinical-stage biotechnology company focused on developing immunotherapies for diseases associated with chronic…
HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors
Investing News Network HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors Co
HCW Biologics sells $1.5M in exempt offering
The offering included equity and rights to acquire another security, with the related security to be acquired upon exercise. HCW Biologics Inc. reported a Rule 506(b) exempt offering with $1,500,000 USD sold and $0 USD remaining to be…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- investingnews.com1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.